Metabotropic Glutamate Receptor 2 Market size is estimated to be USD 1.2 Billion in 2024 and is expected to reach USD 2.5 Billion by 2033 at a CAGR of 8.5% from 2026 to 2033.
The global Metabotropic Glutamate Receptor 2 (mGluR2) market was valued at approximately USD 450 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2023 to 2030. The growing prevalence of neurological disorders and psychiatric conditions, such as anxiety, depression, and schizophrenia, is driving the demand for mGluR2 targeting therapeutics. This market includes research and development investments, drug discovery efforts, and therapeutic applications focused on mGluR2 modulation. The increasing focus on personalized medicine, coupled with advancements in drug delivery systems, is expected to boost market growth in the coming years, especially in regions with high healthcare spending and research activity.
Regionally, North America accounted for the largest share of the mGluR2 market in 2022, contributing over 40% of the global market revenue, largely due to well established healthcare infrastructure, high R&D investments, and a significant presence of pharmaceutical companies. Europe follows closely, with a market share of approximately 30%, driven by growing research initiatives and the increasing adoption of advanced neurological treatments. The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, with a CAGR of 8% due to rising healthcare investments, increasing awareness of neurological conditions, and improving healthcare access. Latin America and the Middle East & Africa are expected to grow steadily, though at a slower pace due to healthcare infrastructure challenges in some regions.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=860632&utm_source=Google site_G_April&utm_medium=235
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=860632&utm_source=Google site_G_April&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global Metabotropic Glutamate Receptor 2 Market
Agonists
Antagonists
Inverse Agonists
Allosteric Modulators
Neurological Disorders
Psychiatric Disorders
Depression
Anxiety Disorders
Post-synaptic Modulation
Pre-synaptic Modulation
Signaling Pathways
Oral
Intravenous
Intranasal
Subcutaneous
Hospitals
Research Institutions
Pharmaceutical Companies
Specialized Clinics
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/metabotropic-glutamate-receptor-2-market/
1. Introduction of the Global Metabotropic Glutamate Receptor 2 Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Metabotropic Glutamate Receptor 2 Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Metabotropic Glutamate Receptor 2 Market, By Type
6. Global Metabotropic Glutamate Receptor 2 Market, By Application
7. Global Metabotropic Glutamate Receptor 2 Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Metabotropic Glutamate Receptor 2 Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/